Nishio Y, Kaku S, Hida S, Ohishi K, Okada Y, Yoshida O
Department of Urology, Faculty of Medicine, Kyoto University.
Hinyokika Kiyo. 1988 Sep;34(9):1593-9.
One hundred and eighty-six patients with primary transitional cell carcinoma underwent radical cystectomy between 1965 to December, 1986. Four of them (2.2%) had developed upper urinary tract transitional cell carcinoma. Three of the 4 patients had received various transurethral treatments for the primary bladder lesions before radical cystectomy, but one patient had undergone total cystectomy and ileal conduit as primary treatment. All of the upper urinary tract tumors were invasive. Three patients died and one is alive. We consider the following to be high risk patients for the development of upper tract recurrence. 1) patients with carcinoma-in-situ and multicentric tumors in the bladder, 2) patients with recurrent bladder cancer treated with bladder preserving treatment for a long periods, 3) patients with vesicoureteral reflux, and 4) occupational bladder cancer patients.
1965年至1986年12月期间,186例原发性移行细胞癌患者接受了根治性膀胱切除术。其中4例(2.2%)发生了上尿路移行细胞癌。4例患者中有3例在根治性膀胱切除术前行经尿道对原发性膀胱病变进行了各种治疗,但1例患者以全膀胱切除术和回肠代膀胱术作为初始治疗。所有上尿路肿瘤均为浸润性。3例患者死亡,1例存活。我们认为以下患者是发生上尿路复发的高危患者:1)膀胱原位癌和多中心肿瘤患者;2)长期接受保膀胱治疗的复发性膀胱癌患者;3)膀胱输尿管反流患者;4)职业性膀胱癌患者。